SCHEMBL14701615

SCHEMBL14701615

CC(C)C(NS(=O)(=O)c1ccccc1)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.58
ALDH1A1 P00352 3/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
MMP2 P08253 4/20 0.52
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
MMP13 P45452 3/20 0.51
ADAMTS4 O75173 3/20 0.51
MMP9 P14780 3/20 0.51
MMP3 P08254 2/20 0.51
MMP1 P03956 2/20 0.51
MMP7 P09237 1/20 0.51
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
MMP8 P22894 1/20 0.48
SLC1A3 P43003 2/20 0.47
SLC1A2 P43004 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18649871 0.89 MMP2 (0.67) MMP2CA12CA9CA14MMP13
SCHEMBL945862 0.83 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL11512348 0.81 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL4714253 0.81 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6006659 0.81 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL5817710 0.80 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6006663 0.79 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL19808134 0.79 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7791079 0.79 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL17318887 0.78 ADAMTS4 (0.62) SMN1; SMN2ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284350-B2 IAP BIR domain binding compounds PHARMASCIENCE INC. (CA) 2016-03-15 US disclosed
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC. (CA) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 SMN1; SMN2 2028/4885ALDH1A1 4122/4885CYP1A2 4811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.